Innovation Centers / Health Disparities Research Center of Excellence

Health Disparities Research Center of Excellence

The HDRCOE seeks to eliminate health disparities, promote health equity, inform public policy, and transform public health practice through the advancement of team science and the application of computational methods, geographic information systems, and spatial temporal analysis through an exposome lens.

The exposome considers the mechanisms and pathways through which the natural, built, social and policy environments affect personal health outcomes and population level disparities across space, time and the life course.

Visit the HDRCOE Website

Health Disparities Research Center of Excellence Administration Team

Paul Juarez, PhD

Professor
School of Medicine
Health Disparities Research Center of Excellence, National Center for Medical Education Development & Research, Tennessee Area Health Education Centers Program

(615) 327-6992
pjuarez@mmc.edu

Terri Cody, MSPH

Fiscal Officer
Health Disparities Research Center of Excellence

tcody@mmc.edu

Health Disparities Research Center of Excellence Research Team

Health Disparities Research Center of Excellence Team Publications

Trending the evidence on opioid use disorder (OUD) continuum of care among rural American Indian/Alaskan Native (AI/AN) tribes: A systematic scoping review.
Mpofu E, Ingman S, Matthews-Juarez P, Rivera-Torres S, Juarez PD

Benzo(a)pyrene-induced cytotoxicity, cell proliferation, DNA damage, and altered gene expression profiles in HT-29 human colon cancer cells.
Myers JN, Harris KL, Rekhadevi PV, Pratap S, Ramesh A

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB

Tim17 Updates: A Comprehensive Review of an Ancient Mitochondrial Protein Translocator.
Chaudhuri M, Darden C, Gonzalez FS, Singha UK, Quinones L, Tripathi A

Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity.
Pajarillo E, Johnson J Jr, Rizor A, Nyarko-Danquah I, Adinew G, Bornhorst J, Stiboller M, Schwerdtle T, Son DS, Aschner M, Lee E

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
Patel JD, Lee JW, Carbone DP, Wagner H, Shanker A, de Aquino MTP, Horn L, Johnson ML, Gerber DE, Liu JJ, Das MS, Al-Nsour MA, Dakhil CSR, Ramalingam S, Schiller JH

Health Disparities Research Center of Excellence

Health Disparities Research Center of Excellence Administration Team

Paul Juarez, PhD

Terri Cody, MSPH

Health Disparities Research Center of Excellence Research Team

Aramandla Ramesh, Ph.D, Ph.D

Anil Shanker, PhD

Donald Alcendor, MS, PhD

Dorin Bogdan Borza, Ph.D.

Deok-Soo Son, DVM, PhD

Julie Gray, DDS, MA

Kathy Jefferson, D.D.S., M.S.

Minu Chaudhuri, PhD

Pandu Gangula, PhD

Paul Juarez, PhD

Ruth Bol, DDS, MPH

Salil Das, Sc.D., D.Sc., Fellow: AAAS; Royal Society of Medicine (UK)

Shyamali Mukherjee, M.Sc, Ph.D

Zhenbang Chen, PhD

Health Disparities Research Center of Excellence Team Publications